Intratumoral heterogeneity of microRNA expression in rectal cancer

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Eriksen, Anne Haahr Mellergaard ^a,b   Andersen, Rikke Fredslund ^a,b   Nielsen, Boye Schnack ^c   Sørensen, Flemming Brandt ^a,b   Appelt, Ane Lindegaard ^a,d   Jakobsen, Anders ^a,b   Hansen, Torben Frøstrup ^a,b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c BIONEER A S   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 125B; MICRORNA 145; MICRORNA 21; MICRORNA 31; MICRORNA 630; UNCLASSIFIED DRUG; MIRN145 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN630 MICRORNA, HUMAN;

ADJUVANT THERAPY; ARTICLE; CANCER GENETICS; CANCER LOCALIZATION; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CANCER; RNA ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; RECTUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; IN VITRO TECHNIQUES; MICRORNAS; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84973452391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156919     Document Type: Article

References (27)

1. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6 (4):259-69. PMID: 16557279
2. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9(2):102-14. doi: 10.1038/nrg2290 PMID: 18197166
3. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009; 8:102. doi: 10.1186/1476-4598-8-102 PMID: 19912656
4. Laurila EM, Kallioniemi A. The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer. 2013.
5. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta. 2010; 411(17-18):1181-6. doi: 10.1016/j.cca.2010.05.002 PMID: 20452339
6. Drebber U, Lay M, Wedemeyer I, Vallbohmer D, Bollschweiler E, Brabender J, et al. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol. 2011; 39(2):409-15. doi: 10.3892/ijo.2011.1036 PMID: 21567082
7. Svoboda M, Izakovicova Holla L, Sefr R, Vrtkova I, Kocakova I, Tichy B, et al. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. Int J Oncol. 2008; 33(3):541-7. PMID: 18695884
8. Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, et al. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. International journal of radiation oncology, biology, physics. 2012; 83(4):1113-9.
9. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2007; 72(5-6):397-402. doi: 10.1159/000113489 PMID: 18196926
10. Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessey E, Sheehan M, et al. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy. Int J Colorectal Dis. 2013; 28(2):247-60. doi: 10.1007/s00384-012-1549-9 PMID: 22903298
11. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008; 9:76. doi: 10.1186/1471-2199-9-76 PMID: 18718003
12. Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer. 2010; 10:173. doi: 10.1186/1471-2407-10-173 PMID: 20429937
13. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. Rna. 2008; 14(5):844-52. doi: 10.1261/rna.939908 PMID: 18375788
14. Wotschofsky Z, Meyer HA, Jung M, Fendler A, Wagner I, Stephan C, et al. Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem. 2011; 417(2):233-41. doi: 10.1016/j.ab.2011.06.009 PMID: 21741950
15. Heppner GH. Tumor heterogeneity. Cancer Res. 1984; 44(6):2259-65. PMID: 6372991
16. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
17. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000; 100(1):57-70. PMID: 10647931
18. Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, et al. Intratumoral heterogeneity of microRNA expression in breast cancer. The Journal of molecular diagnostics: JMD. 2012; 14(4):376-84. doi: 10.1016/j.jmoldx.2012.01.016 PMID: 22704963
19. Peveling-Oberhag J, Seiz A, Doring C, Hartmann S, Koberle V, Liese J, et al. MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor Capsule. Transl Oncol. 2014; 7(6):672-80. doi: 10.1016/j.tranon.2014.09.003 PMID: 25500075
20. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. International journal of radiation oncology, biology, physics. 2009; 74(3):673-88. doi: 10.1016/j.ijrobp.2009.03.003 PMID: 19480968
21. Lim SH, Chua W, Henderson C, Ng W, Shin JS, Chantrill L, et al. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Crit Rev Oncol Hematol. 2015; 96(1):67-80. doi: 10.1016/j.critrevonc.2015.05.003 PMID: 26032919
22. Li T, Leong MH, Harms B, Kennedy G, Chen L. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol. 2013; 19(34):5615-21. doi: 10.3748/wjg.v19.i34.5615 PMID: 24039353
23. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, et al. Clinicopathological significance of micro-RNA-31, -143 and -145 expression in colorectal cancer. Dis Markers. 2009; 26(1):27-34. doi: 10.3233/DMA-2009-0601 PMID: 19242066
24. Eriksen AHM, Andersen RF, Pallisgaard N, Sørensen FB, Jakobsen A, Hansen TF. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer. PloS one. 2016; 11(3):e0150593. doi: 10.1371/journal.pone.0150593 PMID: 26937645
25. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, et al. High levels of micro-RNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2011; 28(1):27-38. doi: 10.1007/s10585-010-9355-7 PMID: 21069438
26. Knudsen KN, Nielsen BS, Lindebjerg J, Hansen TF, Holst R, Sorensen FB. microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. PloS one. 2015; 10(10):e0140503. doi: 10.1371/journal.pone.0140503 PMID: 26465597
27. Jorgensen S, Baker A, Moller S, Nielsen BS. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods. 2010; 52(4):375-81. doi: 10.1016/j.ymeth.2010.07.002 PMID: 20621190